Get started
Author

Laabidi Baraa

Observed name: Baraa Laabidi
ORCID: 0000-0003-2481-8846
Observed ORCID: 0000-0003-2481-8846
OpenAlex ID: A5016014182
Chronic-phase chronic myeloid leukemia: Incidence of BCR/ABL transcript and its correlation with presenting features, response to treatment, and survival
2023 · Baraa Laabidi, Nader Slama, et al. · Leukemia Research Reports · 3
Pb1964: Comparison of Clinico-hematological Parameters and Molecular and Cytogenetic Response of Two Bcr-abl Fusion Transcripts in Chronic Myeloid Leukemia Treated With Imatinib
2023 · Laabidi Baraa, Slama Nader, et al. · HemaSphere · 1
Pb2250: the Impact of Jak2v617f Mutation Positivity in Essential Thrombocythemia:about 74 Cases.
2023 · Arij Cheffai, Slama Nader, et al. · HemaSphere
Pb2241: the Vascular Risk of Essential Thrombocythemia and Reliability of Thrombotic Risk Assessment Scores
2023 · Arij Cheffai, Slama Nader, et al. · HemaSphere
Pb2563: Iron Deficiency Anemia: a Monocentric Experience of the Haematology Department of Monastir, Tunisia
2023 · Donia Bouhoula, Wiem Boufrikha, et al. · HemaSphere
Pb2490: Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio in Patients With Systemic Lupus Erythematosus: a Monocentric Study
2023 · Haifa Tounsi, Laabidi Baraa, et al. · HemaSphere
Evaluation of glycopeptide prescription in high-risk febrile neutropenia: A monocentric study of North Africa
2023 · Wiem Boufrikha, Rim Rakez, et al. · Journal of Oncology Pharmacy Practice
Autoimmune Hemolytic Anemia Revealing a Case of Sarcoidosis
2023 · Tounsi Haifa, Skouri Wafa, et al.
PDF
Works count: 8
Citation count: 4
H-index: 1
I10-index:
Year
Topic
Type